Lamisil (Terbinafine Hydrochloride)

Terbinafine blocks the fungal enzyme squalene epoxidase, preventing the synthesis of ergosterol, an essential component of fungal cell membranes. This leads to a buildup of squalene, disrupting membrane integrity and causing fungal cell death.

The dosage and duration of Lamisil treatment are determined by the prescribing healthcare professional based on the specific infection, its severity, patient age and other clinical factors. Patients should follow the prescriber’s instructions exactly.

Safety of topical terbinafine during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lamisil.

To order Lamisil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamisil (terbinafine) belongs to the allylamine class, which acts by inhibiting squalene epoxidase, whereas azole antifungals (e.g., clotrimazole) inhibit lanosterol 14α‑demethylase. Terbinafine often requires a shorter treatment course and has a favorable safety profile for topical use.

Lamisil should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from excessive moisture, heat and direct sunlight to maintain its stability and effectiveness.

Lamisil is applied topically to the affected skin area, usually once or twice daily as directed by a healthcare professional. The skin should be clean and dry before application, and the medication should be gently rubbed in until fully absorbed.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, extensive skin rash or Stevens‑Johnson syndrome, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms like widespread rash, fever, jaundice or difficulty breathing.

Lamisil should not be used by individuals with a known hypersensitivity to terbinafine or any component of the formulation. It is also contraindicated on severely damaged or inflamed skin and should be used with caution in patients with pre‑existing liver disease.